Codexis Announces Pricing of Public Offering of Common Stock
05 avr. 2018 21h15 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering...
Codexis Announces Proposed Public Offering of Common Stock
05 avr. 2018 16h02 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced that it has commenced an underwritten public offering of...
Codexis to Present at H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco
05 avr. 2018 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., April 05, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at the H.C. Wainwright Global Life...
Worldwide Synthetic Food Market worth over $ 20 billion by 2024: Global Market Insights, Inc.
12 mars 2018 07h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, March 12, 2018 (GLOBE NEWSWIRE) -- Global Synthetic Food Market is expected to surpass USD 20 billion by 2024; according to a new research report by Global Market Insights,...
Codexis Reports 2017 Fourth Quarter and Full Year Financial Results
08 mars 2018 16h05 HE
|
Codexis, Inc.
2017 revenues of $50 million include a 74% increase in product salesIntroduces 2018 financial guidance Conference call begins at 4:30 pm Eastern time todayAccompanying slide presentation available...
Leading Doctor with Enzymedica Addresses Difference Between Digestive Enzymes and Probiotics to Improve Gut Health
01 mars 2018 16h37 HE
|
Enzymedica
VENICE, Fla., March 01, 2018 (GLOBE NEWSWIRE) -- There are trillions of organisms in the human digestive tract that affect what, how and even when we should eat. Of these microbes, some are helpful,...
Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8
01 mars 2018 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial...
Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes Commercialization
15 févr. 2018 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Shawn Clairmont to the newly created position...
Codexis to Present at the 25th International Molecular Medicine Tri-Conference
12 févr. 2018 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the...
Codexis to Present at Two Investment Conferences in November
09 nov. 2017 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two investment conferences in...